Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-22-050612

Chief Medical Officer acquired 612 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tada Hiroomi Chief Medical Officer 2022-09-15 Grant or award +612 $7.66 $4,687 81,237 D
Loading xslF345X03/doc4.xml…